NCT03303950 2022-05-05Allogeneic Stem Cell Transplantation for Multiple Myeloma and MyelofibrosisUniversity of UtahPhase 2 Terminated6 enrolled 17 charts
NCT01447914 2019-08-28Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Completed16 enrolled 11 charts
NCT00416624 2017-02-10Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyMayo ClinicPhase 2 Completed239 enrolled 23 charts
NCT01691040 2014-06-26Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With CancerTME Pharma AGPhase 2 Completed12 enrolled
NCT00301912 2012-10-02Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerUniversity of California, San FranciscoPhase 2 Withdrawn
NCT00095277 2009-03-13Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of CancerAmgenPhase 2 Completed220 enrolled